What is the significance of an implantation hemorrhage seen on ultrasound in the left anterolateral position, measuring 1.3 x 2.7 x 3.0 cm, at 12 weeks gestation, which was slightly larger than a previous measurement of 0.6 x 0.7 x 0.9 cm at 9 weeks gestation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The implantation hemorrhage seen on ultrasound in the left anterolateral position measuring 1.3 x 2.7 x 3.0 cm, which has grown from a previous measurement of 0.6 x 0.7 x 0.9 cm at 9 weeks, represents a subchorionic hematoma that should be monitored but is not necessarily cause for immediate concern. These hematomas occur when blood collects between the chorion (outer fetal membrane) and the uterine wall, and are relatively common in early pregnancy 1. The increasing size between 9 and 12 weeks warrants follow-up ultrasound monitoring, typically in 2-4 weeks, to ensure it resolves or doesn't continue growing significantly.

Key Considerations

  • The growing size suggests active bleeding occurred between the two ultrasounds, but now that you're entering the second trimester, the risk of complications typically decreases as the placenta becomes more firmly established 1.
  • The anterolateral position is generally less concerning than if it were located near the cervix.
  • Patients should report any heavy bleeding, severe cramping, or other concerning symptoms immediately.
  • Most subchorionic hematomas resolve spontaneously without intervention, particularly as pregnancy progresses beyond the first trimester.

Monitoring and Follow-up

  • Follow-up ultrasound monitoring is recommended in 2-4 weeks to ensure the hematoma resolves or doesn't continue growing significantly.
  • No specific medication is typically prescribed for subchorionic hematomas.
  • The primary focus is on monitoring the size and position of the hematoma, as well as the overall health and well-being of the patient.

From the Research

Implantation Haemorrhage Significance

  • Implantation haemorrhage seen on ultrasound can be a significant finding, especially in the context of early pregnancy complications 2.
  • The presence of haemorrhage in the left antero lateral position measuring 1.3 x 2.7 x 3.0 cm, slightly larger than previous measurements, may indicate an abnormal implantation process 2.
  • Abnormal implantation and placentation can lead to pregnancy-related complications, such as pre-eclampsia, preterm labour, and intrauterine growth restriction 2.

Ultrasound Findings and Management

  • Ultrasound findings, including cervical length, distance between the internal cervical os and placenta, and placental edge thickness, can help individualize management of placental implantation abnormalities 3.
  • In cases of first trimester bleeding, ultrasound can help distinguish between normal and abnormal early pregnancy, and guide management decisions 4.
  • The presence of haemorrhage on ultrasound may require closer monitoring and potentially more aggressive management to prevent adverse pregnancy outcomes 3, 4.

Haemostatic System Changes in Pregnancy

  • Pregnancy is associated with unique and profound changes in the hemostatic system, including an increased risk of bleeding during implantation and endovascular trophoblast invasion of the maternal spiral arteries 5.
  • These changes can lead to an increased risk of venous thromboembolism and other haemostatic complications, highlighting the need for careful management and monitoring 5, 6.
  • The diagnosis and management of haemostatic disorders, such as disseminated intravascular coagulation (DIC), require vigilance and knowledge of the physiologic changes during pregnancy 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Using ultrasound in the clinical management of placental implantation abnormalities.

American journal of obstetrics and gynecology, 2015

Research

First Trimester Bleeding: Evaluation and Management.

American family physician, 2019

Research

Pregnancy-associated changes in the hemostatic system.

Clinical obstetrics and gynecology, 2006

Related Questions

What is the most appropriate management for a 25-year-old woman with ongoing vaginal bleeding, a beta human chorionic gonadotropin (HCG) level of 1500, and a transvaginal ultrasound showing a gestational sac without a fetal pole, 2 days after initial presentation with a beta HCG level of 750?
Is it normal to experience vaginal bleeding at 4 weeks of pregnancy when a menstrual period is typically expected?
What is the appropriate evaluation and management for a 40‑year‑old woman presenting with abnormal vaginal spotting?
What is the most appropriate next step for a 17-year-old primigravida (first-time pregnant woman) presenting with mild vaginal bleeding and abdominal cramping at 9 weeks' gestation with a viable intrauterine pregnancy?
What is the management plan for a 13-week pregnant woman with a viable fetus and bleeding, but still has a fetal heartbeat?
Can Mycoplasma hominis (M. hominis) be transmitted to a male partner?
What is the significance of an implantation hemorrhage seen on ultrasound, measuring 1.3 x 2.7 x 3.0 cm, in a pregnancy at 12 weeks gestation, with a previous measurement of 0.6 x 0.7 x 0.9 cm at 9 weeks gestation?
Can Ureaplasma (a type of bacteria) be transmitted to a male partner?
What are 10 clinical characteristics of thyrotoxicosis (hyperthyroidism)?
What are the American guidelines for a 5-year-old boy with congenital perimembranous subaortic Ventricular Septal Defect (VSD) and aortic prolapse with trivial aortic regurgity?
What is the treatment for a mild skin infection of the umbilicus (navel) in an adult?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.